Novartis chemist wins Design a Molecule Competition
Cresset challenged entrants to design a biologically similar molecule to a reference compound
The competition, the third in a series run by the UK developer of software for calculating and comparing the molecular field characteristics of chemical compounds, focused on an anti-malarial target and challenged chemists to design the most biologically similar molecule to a reference compound that was provided.
Entries were ranked relative to the original bioactive/bound conformer using Cresset’s FieldAlign software and then judged on synthetic tractability, drug-likeness and novelty.
Ertl used a triazole replacement to capture the fields provided by both imidazole moieties in the reference to produce a chemically tractable, drug-like molecule.
Albert Kooistra (VU University of Amsterdam) took second prize for engineering an imidazol-sulphonamide bioisostere, which maintained H-bonding interactions to Arginine in the complex.
Welwyn Garden City based Cresset said these well-designed molecules stood in out in a field of strong contenders and congratulated the winners.
The company now plans to run a similar competition early next year.
You may also like
Digital
CMAC unlocks decade of pharmaceutical manufacturing data with Plvs Ultra knowledge graph technology
The University of Strathclyde's CMAC pharmaceutical manufacturing research centre has deployed Plvs Ultra's Enterprise Intelligence Engine to create semantic connections across ten years of previously siloed manufacturing data